Molecular Mechanisms of Amyloidosis
The DOI matches its Crossref record; 86 of the 86 references it cites were found in a registry or an index.
Abstract
Amyloidosis affects millions of people, as a cause of Alzheimer's disease or a complication of dialysis, and also causes rare conditions. The many forms of the disorder have one underlying principle: misfolded proteins. Prompt, correct diagnosis is essential, especially in the inherited forms of amyloidosis. This article reviews the molecular basis of various types of amyloidosis and proposes new ways of treating these disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291
Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins
Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Jarrett, J. T., & Lansbury, P. T. (1993) · Cell · doi:10.1016/0092-8674(93)90635-4 · Cited by 2,178
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Protein misfolding, evolution and disease
Dobson, C. M. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(99)01445-0 · Cited by 1,952
Statins and the risk of dementia
Jick, H., Zornberg, G., Jick, S., Seshadri, S., & Drachman, D. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03155-x · Cited by 1,759
Aβ peptide vaccination prevents memory loss in an animal model of Alzheimer's disease
Morgan, D., Diamond, D. M., Gottschall, P. E., Ugen, K. E., Dickey, C., Hardy, J., Duff, K., Jantzen, P., DiCarlo, G., Wilcock, D., et al. (2000) · Nature · doi:10.1038/35050116 · Cited by 1,498
Cherny, R. A., Atwood, C. S., Xilinas, M. E., Gray, D. N., Jones, W. D., McLean, C. A., Barnham, K. J., Volitakis, I., Fraser, F. W., Kim, Y.-S., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00317-8 · Cited by 1,447
A subset of NSAIDs lower amyloidogenic Aβ42 independently of cyclooxygenase activity
Weggen, S., Eriksen, J. L., Das, P., Sagi, S. A., Wang, R., Pietrzik, C. U., Findlay, K. A., Smith, T. E., Murphy, M. P., Bulter, T., et al. (2001) · Nature · doi:10.1038/35102591 · Cited by 1,388
Alzheimer's Disease and Parkinson's Disease
Nussbaum, R. L., & Ellis, C. E. (2003) · New England Journal of Medicine · doi:10.1056/nejm2003ra020003 · Cited by 1,351
Falk, R. H., Comenzo, R. L., & Skinner, M. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709253371306 · Cited by 1,180
Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis
Booth, D. R., Sunde, M., Bellotti, V., Robinson, C. V., Hutchinson, W. L., Fraser, P. E., Hawkins, P. N., Dobson, C. M., Radford, S. E., Blake, C. C. F., et al. (1997) · Nature · doi:10.1038/385787a0 · Cited by 1,048
Self-citationWhat does it mean to be natively unfolded?
Uversky, V. N. (2002) · European Journal of Biochemistry · doi:10.1046/j.0014-2956.2001.02649.x · Cited by 982
siRNA-mediated gene silencing in vitro and in vivo
Xia, H., Mao, Q., Paulson, H. L., & Davidson, B. L. (2002) · Nature Biotechnology · doi:10.1038/nbt739 · Cited by 873
Hartley, D. M., Walsh, D. M., Ye, C. P., Diehl, T., Vasquez, S., Vassilev, P. M., Teplow, D. B., & Selkoe, D. J. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-20-08876.1999 · Cited by 817
Carrell, R. W., & Lomas, D. A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)02073-4 · Cited by 807
Neurodegenerative Diseases and Prions
Prusiner, S. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105173442006 · Cited by 772
Misdiagnosis of Hereditary Amyloidosis as AL (Primary) Amyloidosis
Lachmann, H. J., Booth, D. R., Booth, S. E., Bybee, A., Gilbertson, J. A., Gillmore, J. D., Pepys, M. B., & Hawkins, P. N. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013354 · Cited by 680
Human lysozyme gene mutations cause hereditary systemic amyloidosis
Pepys, M. B., Hawkins, P. N., Booth, D. R., Vigushin, D. M., Tennent, G. A., Soutar, A. K., Totty, N., Nguyen, O., Blake, C. C. F., Terry, C. J., et al. (1993) · Nature · doi:10.1038/362553a0 · Cited by 657
Kyle, R., Linos, A., Beard, C., Linke, R., Gertz, M., O'Fallon, W., & Kurland, L. (1992) · Blood · doi:10.1182/blood.v79.7.1817.1817 · Cited by 657
Amyloid Fibril Proteins: Proof of Homology with Immunoglobulin Light Chains by Sequence Analyses
Glenner, G. G., Terry, W., Harada, M., Isersky, C., & Page, D. (1971) · Science · doi:10.1126/science.172.3988.1150 · Cited by 590
Targeted pharmacological depletion of serum amyloid P component for treatment of human amyloidosis
Pepys, M. B., Herbert, J., Hutchinson, W. L., Tennent, G. A., Lachmann, H. J., Gallimore, J. R., Lovat, L. B., Bartfai, T., Alanine, A., Hertel, C., et al. (2002) · Nature · doi:10.1038/417254a · Cited by 540
Antibodies inhibit prion propagation and clear cell cultures of prion infectivity
Peretz, D., Williamson, R. A., Kaneko, K., Vergara, J., Leclerc, E., Schmitt-Ulms, G., Mehlhorn, I. R., Legname, G., Wormald, M. R., Rudd, P. M., et al. (2001) · Nature · doi:10.1038/35089090 · Cited by 525
SUNDE, M., & BLAKE, C. C. F. (1998) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583598003400 · Cited by 457
Inflammation and Alzheimer's disease pathogenesis
Rogers, J., Webster, S., Lue, L.-F., Brachova, L., Harold Civin, W., Emmerling, M., Shivers, B., Walker, D., & McGeer, P. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(96)00115-7 · Cited by 442
Tennent, G. A., Lovat, L. B., & Pepys, M. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4299 · Cited by 438
Amyloid-β immunotherapy for Alzheimer's disease: the end of the beginning
Schenk, D. (2002) · Nature Reviews Neuroscience · doi:10.1038/nrn938 · Cited by 436
The fundamentals of protein folding: bringing together theory and experiment
Dobson, C. M., & Karplus, M. (1999) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(99)80012-8 · Cited by 410
Rational design of potent human transthyretin amyloid disease inhibitors.
Sacchettini, J. C., Klabunde, T., Petrassi, H. M., Oza, V. B., Raman, P., & Kelly, J. W. (2000) · Nature Structural Biology · doi:10.1038/74082 · Cited by 379
Kisilevsky, R., Lemieux, L. J., Fraser, P. E., Kong, X., Hultin, P. G., & Szarek, W. A. (1995) · Nature Medicine · doi:10.1038/nm0295-143 · Cited by 363
A role for destabilizing amino acid replacements in light-chain amyloidosis.
Hurle, M. R., Helms, L. R., Li, L., Chan, W., & Wetzel, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.12.5446 · Cited by 348
Deposition of Transthyretin in Early Stages of Familial Amyloidotic Polyneuropathy
Mendes Sousa, M., Cardoso, I., Fernandes, R., Guimarães, A., & Saraiva, M. J. (2001) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63050-7 · Cited by 344
Inhibiting transthyretin amyloid fibril formation via protein stabilization
Miroy, G. J., Lai, Z., Lashuel, H. A., Peterson, S. A., Strang, C., & Kelly, J. W. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.26.15051 · Cited by 344
Receptor-dependent cell stress and amyloid accumulation in systemic amyloidosis
Yan, S. D., Zhu, H., Zhu, A., Golabek, A., Du, H., Roher, A., Yu, J., Soto, C., Schmidt, A. M., Stern, D., et al. (2000) · Nature Medicine · doi:10.1038/76216 · Cited by 343
Protein-misfolding diseases: Getting out of shape
Dobson, C. M. (2002) · Nature · doi:10.1038/418729a · Cited by 341
Khurana, R., Gillespie, J. R., Talapatra, A., Minert, L. J., Ionescu-Zanetti, C., Millett, I., & Fink, A. L. (2001) · Biochemistry · doi:10.1021/bi001782b · Cited by 325
Morozova-Roche, L. A., Zurdo, J., Spencer, A., Noppe, W., Receveur, V., Archer, D. B., Joniau, M., & Dobson, C. M. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4264 · Cited by 319
Comenzo, R. L., Zhang, Y., Martinez, C., Osman, K., & Herrera, G. A. (2001) · Blood · doi:10.1182/blood.v98.3.714 · Cited by 292
Transmissibility of systemic amyloidosis by a prion-like mechanism
Lundmark, K., Westermark, G. T., Nyström, S., Murphy, C. L., Solomon, A., & Westermark, P. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092205999 · Cited by 278
Chiti, F., Calamai, M., Taddei, N., Stefani, M., Ramponi, G., & Dobson, C. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.212527999 · Cited by 273
Local cooperativity in the unfolding of an amyloidogenic variant of human lysozyme
Canet, D., Last, A. M., Tito, P., Sunde, M., Spencer, A., Archer, D. B., Redfield, C., Robinson, C. V., & Dobson, C. M. (2002) · Nature Structural Biology · doi:10.1038/nsb768 · Cited by 227
Permanne, B., Adessi, C., Saborio, G. P., Fraga, S., Frossard, M., Van Dorpe, J., Dewachter, I., Banks, W. A., Van Leuven, F., & Soto, C. (2002) · The FASEB Journal · doi:10.1096/fj.01-0841fje · Cited by 220
Review: Modulating Factors in Amyloid-β Fibril Formation
McLaurin, J., Yang, D.-S., Yip, C. M., & Fraser, P. E. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4289 · Cited by 218
Amyloid Fibril Protein Nomenclature - 2002
(2002) · Amyloid · doi:10.3109/13506120209114823 · Cited by 217
Antibody-Mediated Resolution of Light Chain-Associated Amyloid Deposits
Hrncic, R., Wall, J., Wolfenbarger, D. A., Murphy, C. L., Schell, M., Weiss, D. T., & Solomon, A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64639-1 · Cited by 213
Sousa, M. M., Du Yan, S., Fernandes, R., Guimarães, A., Stern, D., & Saraiva, M. J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07576.2001 · Cited by 212
Hawkins, P. N., Lavender, J. P., Myers, M. J., & Pepys, M. B. (1988) · The Lancet · doi:10.1016/s0140-6736(88)92235-0 · Cited by 209
Merlini, G., Ascari, E., Amboldi, N., Bellotti, V, Arbustini, E., Perfetti, V, Ferrari, M., Zorzoli, I., Marinone, M. G., & Garini, P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.7.2959 · Cited by 205
Self-citationComparison of Lethal and Nonlethal Transthyretin Variants and Their Relationship to Amyloid Disease
McCutchen, S. L., Lai, Z., Miroy, G. J., Kelly, J. W., & Colon, W. (1995) · Biochemistry · doi:10.1021/bi00041a032 · Cited by 198
Establishment of a kinetic model of dialysis-related amyloid fibril extension in vitro
Naiki, H., Hashimoto, N., Suzuki, S., Kimura, H., Nakakuki, K., & Gejyo, F. (1997) · Amyloid · doi:10.3109/13506129709003833 · Cited by 198
Bellotti, V., Mangione, P., & Merlini, G. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4248 · Cited by 190
Self-citationAmyloid P component. A critical review
Pepys, M. B., Booth, D. R., Hutchinson, W. L., Gallimore, J. R., Collins, I. M., & Hohenester, E. (1997) · Amyloid · doi:10.3109/13506129709003838 · Cited by 181
The Genetics of the Amyloidoses
Buxbaum, J. N., & Tagoe, C. E. (2000) · Annual Review of Medicine · doi:10.1146/annurev.med.51.1.543 · Cited by 175
Olofsson, B., Backman, C., Karp, K. H., & Suhr, O. B. (2002) · Transplantation · doi:10.1097/00007890-200203150-00015 · Cited by 169
Benson, M. D., Liepnieks, J. J., Yazaki, M., Yamashita, T., Asl, K. H., Guenther, B. D., & Kluve‐Beckerman, B. (2001) · Genomics · doi:10.1006/geno.2000.6499 · Cited by 169
β 2‐Microglobulin and amyloidosis
Drüeke, T. B. (2000) · Nephrology Dialysis Transplantation · doi:10.1093/oxfordjournals.ndt.a027958 · Cited by 169
Yazaki, M., Tokuda, T., Nakamura, A., Higashikata, T., Koyama, J., Higuchi, K., Harihara, Y., Baba, S., Kametani, F., & Ikeda, S.-I. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3203 · Cited by 168
Alzheimer's disease: treatments in discovery and development
Citron, M. (2002) · Nature Neuroscience · doi:10.1038/nn940 · Cited by 165
The solution structure of human β2‐microglobulin reveals the prodromes of its amyloid transition
Verdone, G., Corazza, A., Viglino, P., Pettirossi, F., Giorgetti, S., Mangione, P., Andreola, A., Stoppini, M., Bellotti, V., & Esposito, G. (2002) · Protein Science · doi:10.1110/ps.29002 · Cited by 158
Self-citationFurin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia
Kim, S.-H., Wang, R., Gordon, D. J., Bass, J., Steiner, D. F., Lynn, D. G., Thinakaran, G., Meredith, S. C., & Sisodia, S. S. (1999) · Nature Neuroscience · doi:10.1038/14783 · Cited by 154
Chemical Typing of Amyloid Protein Contained in Formalin-Fixed Paraffin-Embedded Biopsy Specimens
Murphy, C. L., Eulitz, M., Hrncic, R., Sletten, K., Westermark, P., Williams, T. K., Macy, S. D., Wooliver, C., Wall, J. S., Weiss, D. T., et al. (2001) · American Journal of Clinical Pathology · doi:10.1309/twbm-8l4e-vk22-frh5 · Cited by 151
Furin initiates gelsolin familial amyloidosis in the Golgi through a defect in Ca2+ stabilization
Chen, C.-D., Huff, M. E., Matteson, J., Page, L. J., Phillips, R., Kelly, J. W., & Balch, W. E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.22.6277 · Cited by 148
Review: Amyloidogenesis—Unquestioned Answers and Unanswered Questions
Kisilevsky, R. (2000) · Journal of Structural Biology · doi:10.1006/jsbi.2000.4222 · Cited by 148
Only amyloidogenic intermediates of transthyretin induce apoptosis
Andersson, K., Olofsson, A., Nielsen, E. H., Svehag, S., & Lundgren, E. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00465-5 · Cited by 139
Secretase Targets for Alzheimer's Disease: Identification and Therapeutic Potential
Wolfe, M. S. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0004897 · Cited by 133
Potential role of apolipoprotein-E in fibrillogenesis.
Gallo, G., Wısnıewskı, T., Choi-Miura, N.-H., Ghiso, J. A., & Frangione, B. (1994) · PubMed · Cited by 131
Abrahamson, M., & Grubb, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1416 · Cited by 129
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124
Domain Stability in Immunoglobulin Light Chain Deposition Disorders
Wetzel, R. B. (1997) · Advances in protein chemistry · doi:10.1016/s0065-3233(08)60322-8 · Cited by 120
Illuminating folding intermediates.
Schultz, C. P. (2000) · Nature Structural Biology · doi:10.1038/71197 · Cited by 112
Proteolysis of AA Amyloid Fibril Proteins by Matrix Metalloproteinases-1, -2, and -3
Stix, B., Kähne, T., Sletten, K., Raynes, J. G., Roessner, A., & Röcken, C. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61727-0 · Cited by 111
Transthyretin amyloidosis: a tale of weak interactions
Saraiva, M. J. M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02480-2 · Cited by 97
Counteracting Effects of Renal Solutes on Amyloid Fibril Formation by Immunoglobulin Light Chains
Kim, Y., Cape, S. P., Chi, E. Y., Wilton, R., Stevens, P. W., Stevens, F. J., Manning, M. C., Randolph, T. W., Solomon, A., & Carpenter, J. F. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007766200 · Cited by 94
Conformational Switching and Fibrillogenesis in the Amyloidogenic Fragment of Apolipoprotein A-I
Andreola, A., Bellotti, V., Giorgetti, S., Mangione, P. P., Obici, L. P., Stoppini, M., Torres, J., Monzani, E., Merlini, G., & Sunde, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204801200 · Cited by 93
Self-citationPeptide Inhibitors of Beta Amyloid Aggregation
Findeis, M. A. (2002) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026024607508 · Cited by 90
Gillmore, J. D., Stangou, A. J., Tennent, G. A., Booth, D. R., Grady, J. O., Rela, M., Heaton, N. D., Wall, C. A. M., Keogh, J. A. B., & Hawkins, P. N. (2001) · Transplantation · doi:10.1097/00007890-200104150-00026 · Cited by 74
4′-Iodo-4′-Deoxydoxorubicin Disrupts the Fibrillar Structure of Transthyretin Amyloid
Palha, J. A., Ballinari, D., Amboldi, N., et al. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65065-1 · Cited by 60
Genetic clues to understanding periodic fevers, and possible therapies
McDermott, M. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02425-5 · Cited by 46
Inhibition of Amyloid Fiber Assembly by Both BiP and Its Target Peptide
Davis, D. P., Wilton, R., Dul, J. L., Vogen, S. M., Williamson, E. K., Stevens, F. J., & Argon, Y. (2000) · Immunity · doi:10.1016/s1074-7613(00)00043-1 · Cited by 44
SEBASTIÃO, M. P., Merlini, G., Saraiva, M. J., & Damas, A. M. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510273 · Cited by 43
Self-citationFunctional neuroimaging in Alzheimer's type dementia
Demetriades, A. K. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00299-x · Cited by 34
[42] Senescence-accelerated mouse
Higuchi, K., Hosokawa, M., & Takeda, T. (1999) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(99)09044-8 · Cited by 29
Amyloid Enhancing Factor and Dietary Transmission in Accelerated Amyloid A Amyloidosis
Elliott-Bryant, R., & Cathcart, E. S. (1998) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1998.4555 · Cited by 26
Apolipoprotein E and Amyloidogenesis
Frangione, B., Castaño, E. M., Wısnıewskı, T., Ghiso, J. A., Prelli, F., & Vidal, R. (2007) · Novartis Foundation symposium · doi:10.1002/9780470514924.ch9 · Cited by 18
Cited by
Protein Misfolding, Functional Amyloid, and Human Disease
Chiti, F., & Dobson, C. M. (2006) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.101304.123901 · Cited by 6,423
Clinical and biomarker changes in dominantly inherited Alzheimer's disease
Bateman, R. J., Xiong, C., Benzinger, T. L. S., Fagan, A. M., Goate, A., Fox, N. C., Marcus, D. S., Cairns, N. J., Xie, X., Blazey, T. M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202753 · Cited by 3,814
Townsend, R. R., Wilkinson, I. B., Schiffrin, E. L., Avolio, A. P., Chirinos, J. A., Cockcroft, J. R., Heffernan, K. S., Lakatta, E. G., McEniery, C. M., Mitchell, G. F., et al. (2015) · Hypertension · doi:10.1161/hyp.0000000000000033 · Cited by 1,473
Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis
Benson, M. D., Waddington-Cruz, M., Berk, J. L., Polydefkis, M., Dyck, P. J., Wang, A. K., Planté-Bordeneuve, V., Barroso, F. A., Merlini, G., Obici, L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1716793 · Cited by 1,452
Self-citationIslet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044
“In amyloidogenesis in general, the molecules deposited in the fibrils have undergone some degree of proteolysis, and only rarely are unprocessed proteins found (77, 102, 243).”
Background
Metadata
- Authors
- Merlini, G., & Bellotti, V.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2003-08-07
- Volume
- 349
- Issue
- 6
- Pages
- 583-596
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2161648900
- Cited by
- 1,920
- References
- 86
- FWCI
- 16.19
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.